A US national view of prevalent and newly diagnosed multiple myeloma in 2021: A retrospective analysis of national all-payer claims database

Impact of patient race on insurance payor switch rate, healthcare resource utilization, and cost among adult patients with schizophrenia in the United States: An analysis of RWD Insights all payer claims database

Abstract Objectives: Switches from Commercial to Medicaid insurance may impact patient access and healthcare resource use. We descriptively assessed payor switch rate, HCRU, and costs by race for patients with schizophrenia.  Methods: STATinMED RWD Insights (all-payer...
A US national view of prevalent and newly diagnosed multiple myeloma in 2021: A retrospective analysis of national all-payer claims database

Evaluation of treatment patterns among Crohn’s disease patients initiating biologics with three years of follow-up

Abstract Objective: This study examined biologic treatment patterns among Crohn’s Disease (CD)-related patients initiating biologics over a 3-year follow-up period. Methods: This descriptive study used All Payers Claims Data (APCD) from Sep 2015 to Oct 2021. Adult...
A US national view of prevalent and newly diagnosed multiple myeloma in 2021: A retrospective analysis of national all-payer claims database

Impact of patient race on insurance payor switch rate, healthcare resource utilization, and cost among adult patients with schizophrenia in the United States: An analysis of RWD Insights all payer claims database

Abstract Background Patient access and healthcare resource use (HCRU) can be impacted by switches from Commercial to Medicaid insurance.   Objectives Descriptively assess payor switch rate, HCRU, and costs by race for patients with schizophrenia  Methods STATinMED RWD...